EDSA - CIK 0001540159
The table below shows Edesa Biotech, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $10.00M | $12.10M | $12.40M | $13.90M | $1.60M | - |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $10.42M |
| $12.72M |
| $12.76M |
| $14.39M |
| $2.07M |
| $3.05M |
| Property, plant & equipment | - | - | - | - | - | $0.00 |
| Goodwill | - | - | - | - | - | - |
| Total assets | $12.38M | $14.71M | $14.80M | $16.45M | $4.16M | $5.23M |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $2.19M | $756.16K | $672.67K | $914.70K | $1.90M | $2.36M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | - | - | $2.36M |
| Retained earnings | -$72.45M | -$68.20M | -$63.65M | -$61.86M | -$60.23M | -$57.63M |
| Total equity | $10.20M | $13.95M | $14.13M | $15.54M | $2.26M | $2.87M |